“Omalizumab Retreatment of Patients with Chronic Idiopathic Urticaria/Spontaneous Urticaria (CIU/CS) Following Return of Symptoms: Primary Results of the Optima Study”, J of Skin, vol. 2, no. S1, p. S54, Feb. 2018, doi: 10.25251/skin.2.supp.54.